<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-056132</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Kaposi sarcoma associated with systemic corticosteroid therapy</dc:title>
<dc:description xml:lang="en">Kaposi sarcoma (KS) was first described in 1872 by Moritz Kaposi. Its epidemiology is suggestive of an infectious disease and in 1994 Chang and coworkers identified DNA sequences corresponding to a previously unidentified herpes virus--human herpes virus 8 (HHV-8)--in AIDS-associated KS biopsies. It is now believed that the presence of HHV-8 is a necessary condition but not sufficient on its own to cause KS. Other factors such as immunosuppression should also be considered and it is known that immunosuppressive therapy increases the risk of KS.         We describe a patient who developed KS after prolonged prednisone therapy for temporal arteritis</dc:description>
<dc:creator>Cruces, M</dc:creator>
<dc:creator>Mayo, E</dc:creator>
<dc:creator>González-Sixto, B</dc:creator>
<dc:creator>Pardavila, E</dc:creator>
<dc:creator>Conde, A</dc:creator>
<dc:creator>Torre, C de la</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El sarcoma de Kaposi (SK) fue descrito por Moritz Kaposi en 1872. Las características epidemiológicas del SK apuntan a una probable causa infecciosa. Se han identificado fragmentos de ADN que corresponden a un virus herpes no identificado previamente, el virus herpes humano tipo 8, en biopsias de SK asociado a sida. Se considera un factor necesario pero no suficiente, siendo conveniente tener en cuenta otros factores como la inmunosupresión. Los tratamientos inmunosupresores se asocian con un mayor riesgo de desarrollar SK.         Describimos el caso de un paciente que desarrolló SK tras recibir tratamiento prolongado con prednisona con motivo de la arteritis de la temporal que padecía</dc:description>
<dc:source>Actas Dermosifiliogr;98(8): 553-555, oct. 2007. ilus</dc:source>
<dc:identifier>ibc-056132</dc:identifier>
<dc:title xml:lang="es">Sarcoma de Kaposi asociado a corticoterapia sistémica</dc:title>
<dc:subject>^d12893^s22036</dc:subject>
<dc:subject>^d308^s22020</dc:subject>
<dc:subject>^d22622^s22073</dc:subject>
<dc:subject>^d14078^s22057</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30040</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:type>article</dc:type>
<dc:date>200710</dc:date>
</metadata>
</record>
</ibecs-document>
